SAS Drug Development prior 32DRG02 Logout input validation

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
7.4$0-$5k0.00

A vulnerability was found in SAS Drug Development. It has been declared as critical. Affected by this vulnerability is some unknown functionality of the component Logout Handler. The manipulation with an unknown input leads to a input validation vulnerability. The CWE definition for the vulnerability is CWE-20. The product receives input or data, but it does not validate or incorrectly validates that the input has the properties that are required to process the data safely and correctly. As an impact it is known to affect confidentiality, integrity, and availability. The summary by CVE is:

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

The weakness was disclosed 07/31/2019. This vulnerability is known as CVE-2007-6763 since 07/30/2019. The attack can be launched remotely. A single authentication is required for exploitation. Neither technical details nor an exploit are publicly available.

Upgrading to version 32DRG02 eliminates this vulnerability.

Productinfo

Name

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB CVSS-B Score: 🔍
VulDB CVSS-BT Score: 🔍
VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 7.5
VulDB Meta Temp Score: 7.4

VulDB Base Score: 6.3
VulDB Temp Score: 6.0
VulDB Vector: 🔍
VulDB Reliability: 🔍

NVD Base Score: 8.8
NVD Vector: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
unlockunlockunlockunlockunlockunlock
unlockunlockunlockunlockunlockunlock
unlockunlockunlockunlockunlockunlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍

Exploitinginfo

Class: Input validation
CWE: CWE-20
CAPEC: 🔍
ATT&CK: 🔍

Local: No
Remote: Yes

Availability: 🔍
Status: Not defined

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-Dayunlockunlockunlockunlock
Todayunlockunlockunlockunlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

0-Day Time: 🔍

Upgrade: SAS Drug Development 32DRG02

Timelineinfo

07/30/2019 🔍
07/31/2019 +1 days 🔍
08/01/2019 +1 days 🔍
11/14/2023 +1566 days 🔍

Sourcesinfo

Advisory: ftp.sas.com
Status: Not defined

CVE: CVE-2007-6763 (🔍)

Entryinfo

Created: 08/01/2019 08:59 AM
Updated: 11/14/2023 01:44 PM
Changes: 08/01/2019 08:59 AM (36), 07/16/2020 02:19 PM (17), 11/14/2023 01:44 PM (4)
Complete: 🔍
Cache ID: 18:989:40

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Interested in the pricing of exploits?

See the underground prices here!